Loading the records…
Carol Devine Miller
RepublicanWV01•house•Filed Apr 11, 2025
View all of Carol Devine Miller's trades →14 total filings on record
Carol Devine Miller (R-WV) bought $1K-$15K of $GILD (Gilead Sciences, Inc. - Common Stock (GILD) [ST]) on Mar 10, 2025, part of 14 transactions in this filing (9 buys, 5 sells).
HillSignal flagged 5 timing concerns on this filing — trades that line up closely with related legislative or contract activity.
Transactions
14
Companies
4
Largest Trade
$1K-$15K
Timing Flags
5
Companies in this filing · 4
Price Movement Since Trade
How the largest positions have moved from the trade date to the most recent close.
Trade Day
$117.21
Mar 10, 2025
Current
$126.33
Jun 29, 2026
Change
+7.78%
+$9.12
Trade Day
$156.25
Mar 10, 2025
Current
$137.43
Jun 30, 2026
Change
-12.04%
$-18.82
Trade Day
$42.37
Mar 10, 2025
Current
$61.28
Jun 29, 2026
Change
+44.63%
+$18.91
Trade Day
$113.85
Mar 10, 2025
Current
$130.50
Jun 30, 2026
Change
+14.62%
+$16.65
🔒
Sign Up to See More
See the full trade breakdown, suspicious timing flags, and how this filing connects to active legislation.
Get Free Access →Timing Flags
5 flags1.
Rep. Carol Devine Miller sold $1,001 - $15,000 in $UPS on March 10, 2025 — 30 days before the "Protecting Employees and Retirees in Business Bankruptcies Act of 2025" (S. 1381) was introduced, a bill with potential bearish implications for corporations.
2.
Rep. Carol Devine Miller bought $1,001 - $15,000 in $GILD on March 10, 2025 — 17 days before the "Providing Veterans Essential Medications Act" (HR1970) was introduced, a bill potentially beneficial for pharmaceutical companies.
3.
Rep. Carol Devine Miller bought $1,001 - $15,000 in $LMT on March 10, 2025 — 22 days before the "Taiwan Allies Fund Act" (HR2559) was introduced, a bill potentially beneficial for defense contractors.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $GILD | Gilead Sciences, Inc. - Common Stock (GILD) [ST] | $1K-$15K | $117.21 | $126.33 | +7.8% | Mar 10, 2025 |
| BUY | $PEP | PepsiCo, Inc. - Common Stock (PEP) [ST] | $1K-$15K | $156.25 | $137.43 | -12.0% | Mar 10, 2025 |
| BUY | $HON | Honeywell International Inc. - Common Stock | $1K-$15K | $427.64 | $224.28 | -47.6% | Mar 10, 2025 |
| BUY | $HSY | The Hershey Company Common Stock | $1K-$15K | $186.36 | $178.22 | -4.4% | Mar 10, 2025 |
| BUY | $ITW | Illinois Tool Works Inc. Common Stock | $1K-$15K | $267.67 | $267.47 | -0.1% | Mar 10, 2025 |
| BUY | $LMT | Lockheed Martin Corporation Common Stock | $1K-$15K | $479.17 | $504.36 | +5.3% | Mar 10, 2025 |
| BUY | $AFL | AFLAC Incorporated Common Stock | $1K-$15K | $106.76 | $120.08 | +12.5% | Mar 10, 2025 |
| BUY | $AWK | American Water Works Company, Inc. Common Stock | $1K-$15K | $149.31 | $132.41 | -11.3% | Mar 10, 2025 |
| BUY | $CME | CME Group Inc. - Class A Common Stock | $1K-$15K | $262.28 | $218.58 | -16.7% | Mar 10, 2025 |
| SELL | $USB | U.S. Bancorp Common Stock (USB) [ST] | $1K-$15K | $42.37 | $61.28 | +44.6% | Mar 10, 2025 |
BUY$1K-$15K
$GILDGilead Sciences, Inc. - Common Stock (GILD) [ST]
$117.21 \u2192 $126.33+7.8%
Mar 10, 2025 \u2022 self
BUY$1K-$15K
$PEPPepsiCo, Inc. - Common Stock (PEP) [ST]
$156.25 \u2192 $137.43-12.0%
Mar 10, 2025 \u2022 self
BUY$1K-$15K
$HONHoneywell International Inc. - Common Stock
$427.64 \u2192 $224.28-47.6%
Mar 10, 2025 \u2022 self
BUY$1K-$15K
$ITWIllinois Tool Works Inc. Common Stock
$267.67 \u2192 $267.47-0.1%
Mar 10, 2025 \u2022 self
BUY$1K-$15K
$LMTLockheed Martin Corporation Common Stock
$479.17 \u2192 $504.36+5.3%
Mar 10, 2025 \u2022 self
BUY$1K-$15K
$AWKAmerican Water Works Company, Inc. Common Stock
$149.31 \u2192 $132.41-11.3%
Mar 10, 2025 \u2022 self
BUY$1K-$15K
$CMECME Group Inc. - Class A Common Stock
$262.28 \u2192 $218.58-16.7%
Mar 10, 2025 \u2022 self
SELL$1K-$15K
$USBU.S. Bancorp Common Stock (USB) [ST]
$42.37 \u2192 $61.28+44.6%
Mar 10, 2025 \u2022 self
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
BillHR2559neutral
Taiwan Allies Fund Act
The Taiwan Allies Fund Act (HR2559) is an early-stage authorization bill with $0 funding that has been stalled in the House Foreign Affairs Committee for over a year with no legislative action. It carries zero near-term market impact for any traded security, including TSM, which remains driven by semiconductor fundamentals and real appropriations bills like the CHIPS Act.
Apr 1, 2025
BillS956bullish
Customs Facilitation Act of 2025
The Customs Facilitation Act of 2025 (S.956) mandates a uniform automated cargo processing platform and continuous ACE modernization. It is a structural efficiency gain for logistics intermediaries like $CHRW and $JBHT, reducing customs friction and improving asset turns. $ORCL is positioned to bid on the IT modernization contracts that follow. At $186.2 and $245.89 respectively, $CHRW and $JBHT have already priced in 12-16% gains over 30 days. The bill is early-stage (referred to Senate Finance), so the market reaction reflects the long-term structural thesis, not imminent passage.
Mar 11, 2025
BillHR2511bearish
Sarah Katz Caffeine Safety Act
The Sarah Katz Caffeine Safety Act (HR2511) imposes new caffeine labeling and menu disclosure requirements on beverage manufacturers and restaurant chains. The bill is in early committee stage with no markup scheduled—near-term market impact is minimal. Pure-play energy drink company $MNST faces the highest relative compliance cost burden, while $SBUX faces menu redesign costs. Diversified giants $KO and $PEP have negligible relative impact.
Mar 31, 2025
BillHR2381bullish
SCREENS for Cancer Act of 2025
The SCREENS for Cancer Act reauthorizes and expands national cancer screening programs for 2026-2030. This creates a structural volume tailwind for Labcorp ($LH) and Quest Diagnostics ($DGX) as the primary processors of screening lab work. Both stocks have been down over the past month on broader market weakness, not bill-specific news — the authorization provides a real federal program pipeline for incremental testing revenue once appropriations are secured.
Mar 26, 2025
BillHR2678bullish
Ellie’s Law
Ellie's Law (HR2678) is an early-stage authorization bill directing NINDS to research unruptured intracranial aneurysms. It authorizes zero dollars, has no funding appropriation, and has only been referred to committee. Market impact is negligible in the near term for device and research tool providers like MDT, TMO, ILMN, and DGX, as no actual spending exists and the legislative path is years from completion.
Apr 7, 2025
BillHR1970bullish
Providing Veterans Essential Medications Act
HR1970 (Providing Veterans Essential Medications Act) is in early legislative stages, having been referred to the House Veterans' Affairs subcommittee. The bill mandates VA reimbursement for high-cost medications dispensed to veterans in State nursing homes, but authorizes no specific funding and remains months from passage. Real market data shows CVS up 16% in 30 days while CAH is down 10%, reflecting broader distribution-sector dynamics rather than this early-stage bill.
Mar 27, 2025
BillS1031bearish
ROCR Value Based Program Act
S.1031 (ROCR Value Based Program Act) is an early-stage bill proposing a shift to bundled Medicare payments for radiation oncology. It presents a structural long-term bearish signal for equipment vendors like GE HealthCare ($GEHC) but has no near-term market impact due to its early legislative stage and absence of funding. $GEHC is already down 16% in 30 days, trading at $59.66 near its 52-week low of $58.75.
Mar 13, 2025
BillHR2075bearish
Protecting Life and Integrity in Research Act of 2025
HR2075 is an early-stage House bill that would ban federal funding for research using human fetal tissue from induced abortions. It is stuck in committee with no floor action since introduction in March 2025. The market data shows a broad 30-day decline across biomedical stocks, but $TMO and $DHR have moved -1.19% and +0.72% respectively in the past 7 days — not signaling acute legislative risk. The bill has zero direct appropriations and remains a low-probability risk factor for life sciences tool suppliers.
Mar 11, 2025
BillHR2059bearish
To prohibit the issuance of licenses for the exportation of certain defense articles to the United Arab Emirates, and for other purposes.
HR2059 directly prohibits defense article exports to the UAE until it certifies cessation of support for the Rapid Support Forces in Sudan. This bill blocks multi-billion dollar F-35 (Lockheed), F-15 (Boeing), Patriot (RTX), and armored vehicle (General Dynamics) sales to a top-tier Middle East customer. The defense sector faces a direct revenue headwind, with Lockheed Martin most exposed given its $512 level and 7-day decline of -7.77%.
Mar 11, 2025
BillS1045bullish
Aviation Funding Stability Act of 2025
The Aviation Funding Stability Act (S.1045) is a procedural bill in early committee stage (referred to Finance, not yet passed) that would guarantee FAA funding from the Airport and Airway Trust Fund during government shutdowns. For $BA, $LMT, and $RTX, this removes a discrete operational risk to FAA-dependent programs, but near-term market impact is low given the bill's early legislative stage. Market data shows all three stocks under pressure in the past 30 days: $BA down 2.4% in the past week despite a +14% monthly gain, $LMT down 15.6% monthly, and $RTX down 9.6% monthly.
Mar 13, 2025
Other Filings by Carol Devine Miller
Free — no credit card
Get the next Miller trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.